369 related articles for article (PubMed ID: 22463980)
1. Breaking the chain: Rift Valley fever virus control via livestock vaccination.
Bird BH; Nichol ST
Curr Opin Virol; 2012 Jun; 2(3):315-23. PubMed ID: 22463980
[TBL] [Abstract][Full Text] [Related]
2. Modelling Vaccination Strategies against Rift Valley Fever in Livestock in Kenya.
Gachohi JM; Njenga MK; Kitala P; Bett B
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005049. PubMed ID: 27973528
[TBL] [Abstract][Full Text] [Related]
3. Observations on rift valley fever virus and vaccines in Egypt.
Ahmed Kamal S
Virol J; 2011 Dec; 8():532. PubMed ID: 22152149
[TBL] [Abstract][Full Text] [Related]
4. Estimation of Rift Valley fever virus spillover to humans during the Mayotte 2018-2019 epidemic.
Métras R; Edmunds WJ; Youssouffi C; Dommergues L; Fournié G; Camacho A; Funk S; Cardinale E; Le Godais G; Combo S; Filleul L; Youssouf H; Subiros M
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24567-24574. PubMed ID: 32929025
[TBL] [Abstract][Full Text] [Related]
5. [Rift Valley fever].
Pépin M;
Med Mal Infect; 2011 Jun; 41(6):322-9. PubMed ID: 21295425
[TBL] [Abstract][Full Text] [Related]
6. One Health approach to Rift Valley fever vaccine development.
Kortekaas J
Antiviral Res; 2014 Jun; 106():24-32. PubMed ID: 24681125
[TBL] [Abstract][Full Text] [Related]
7. Rift Valley Fever: An Emerging Mosquito-Borne Disease.
Linthicum KJ; Britch SC; Anyamba A
Annu Rev Entomol; 2016; 61():395-415. PubMed ID: 26982443
[TBL] [Abstract][Full Text] [Related]
8. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
Terasaki K; Tercero BR; Makino S
Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
[TBL] [Abstract][Full Text] [Related]
9. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
Ikegami T
Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
[TBL] [Abstract][Full Text] [Related]
10. Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.
Bird BH; Maartens LH; Campbell S; Erasmus BJ; Erickson BR; Dodd KA; Spiropoulou CF; Cannon D; Drew CP; Knust B; McElroy AK; Khristova ML; Albariño CG; Nichol ST
J Virol; 2011 Dec; 85(24):12901-9. PubMed ID: 21976656
[TBL] [Abstract][Full Text] [Related]
11. Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021.
Gerken KN; LaBeaud AD; Mandi H; L'Azou Jackson M; Breugelmans JG; King CH
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009852. PubMed ID: 35073355
[TBL] [Abstract][Full Text] [Related]
12. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
[TBL] [Abstract][Full Text] [Related]
13. Relevance of Rift Valley fever to public health in the European Union.
Chevalier V
Clin Microbiol Infect; 2013 Aug; 19(8):705-8. PubMed ID: 23517372
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of Rift Valley fever virus in livestock during inter-epidemic period in Egypt, 2014/15.
Mroz C; Gwida M; El-Ashker M; El-Diasty M; El-Beskawy M; Ziegler U; Eiden M; Groschup MH
BMC Vet Res; 2017 Apr; 13(1):87. PubMed ID: 28381251
[TBL] [Abstract][Full Text] [Related]
15. Rift Valley fever seroprevalence and abortion frequency among livestock of Kisoro district, South Western Uganda (2016): a prerequisite for zoonotic infection.
Budasha NH; Gonzalez JP; Sebhatu TT; Arnold E
BMC Vet Res; 2018 Sep; 14(1):271. PubMed ID: 30176865
[TBL] [Abstract][Full Text] [Related]
16. High risk for human exposure to Rift Valley fever virus in communities living along livestock movement routes: A cross-sectional survey in Kenya.
Tigoi C; Sang R; Chepkorir E; Orindi B; Arum SO; Mulwa F; Mosomtai G; Limbaso S; Hassan OA; Irura Z; Ahlm C; Evander M
PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007979. PubMed ID: 32084127
[TBL] [Abstract][Full Text] [Related]
17. Distribution and abundance of key vectors of Rift Valley fever and other arboviruses in two ecologically distinct counties in Kenya.
Sang R; Arum S; Chepkorir E; Mosomtai G; Tigoi C; Sigei F; Lwande OW; Landmann T; Affognon H; Ahlm C; Evander M
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005341. PubMed ID: 28212379
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.
Miller MM; Bennett KE; Drolet BS; Lindsay R; Mecham JO; Reeves WK; Weingartl HM; Wilson WC
Clin Vaccine Immunol; 2015 Aug; 22(8):930-7. PubMed ID: 26041042
[TBL] [Abstract][Full Text] [Related]
19. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.
Kortekaas J; de Boer SM; Kant J; Vloet RP; Antonis AF; Moormann RJ
Vaccine; 2010 Jun; 28(27):4394-401. PubMed ID: 20434545
[TBL] [Abstract][Full Text] [Related]
20. [Present status of an arbovirus infection: yellow fever, its natural history of hemorrhagic fever, Rift Valley fever].
Digoutte JP
Bull Soc Pathol Exot; 1999 Dec; 92(5):343-8. PubMed ID: 10690474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
